Suppr超能文献

导管消融治疗心房颤动:当前适应证和不断发展的技术。

Catheter ablation for atrial fibrillation: current indications and evolving technologies.

机构信息

Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.

Department of Medicine, University of Melbourne, Melbourne, Australia.

出版信息

Nat Rev Cardiol. 2021 Mar;18(3):210-225. doi: 10.1038/s41569-020-00451-x. Epub 2020 Oct 13.

Abstract

Catheter ablation for atrial fibrillation (AF) has emerged as an important rhythm-control strategy and is by far the most common cardiac ablation procedure performed worldwide. Current guidelines recommend the procedure in symptomatic patients with paroxysmal or persistent AF who are refractory or intolerant to antiarrhythmic drugs. The procedure might also be considered as a first-line approach in selected asymptomatic patients. Data from large registries indicate that AF ablation might reduce mortality and the risk of heart failure and stroke, but evidence from randomized controlled trials is mixed. Pulmonary vein isolation using point-by-point radiofrequency or with the cryoballoon remains the cornerstone technique in AF ablation. Additional atrial ablation can be performed in patients with persistent AF, but its benefits are largely unproven. Technological advances in the past decade have focused on achieving durable vein isolation, reducing procedure duration and improving safety. Numerous exciting new technologies are in various stages of development. In this Review, we discuss the relevant data to support the recommended and evolving indications for catheter ablation of AF, describe the different ablation techniques, and highlight the latest advances in technology that aim to improve its safety and efficacy. We also discuss lifestyle modification strategies to improve ablation outcomes.

摘要

导管消融术治疗心房颤动 (AF) 已成为一种重要的节律控制策略,是目前全球范围内最常进行的心脏消融术。目前的指南建议在对心律失常药物不耐受或无效的阵发性或持续性 AF 有症状患者中进行该操作。在某些无症状患者中,也可以考虑将其作为一线治疗方法。来自大型注册研究的数据表明,AF 消融可能降低死亡率和心力衰竭及中风的风险,但随机对照试验的证据并不一致。使用逐点射频或冷冻球囊的肺静脉隔离仍然是 AF 消融的基石技术。在持续性 AF 患者中可以进行额外的心房消融,但其益处尚未得到充分证实。过去十年中的技术进步主要集中在实现持久的静脉隔离、缩短手术时间和提高安全性上。许多令人兴奋的新技术处于不同的开发阶段。在这篇综述中,我们讨论了支持导管消融治疗 AF 的推荐和不断发展的适应证的相关数据,描述了不同的消融技术,并强调了旨在提高安全性和疗效的最新技术进展。我们还讨论了改善消融结果的生活方式改变策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验